Gremlins: Is this what renal fibrogenesis has come to?

Madeline Murphy, Ruth McMahon, David W.P. Lappin, Hugh R. Brady

Research output: Contribution to a Journal (Peer & Non Peer)Short surveypeer-review

20 Citations (Scopus)

Abstract

Gremlin is a member of the differential screening-selected gene aberrative in the neuroblastoma (DAN) family of bone morphogenetic protein (BMP) antagonists. Gremlin influences diverse processes in growth, differentiation and development. Increased expression of gremlin has recently been demonstrated in several models of diabetic nephropathy. Gremlin arrests the cell cycle in mesangial cells and has also been shown to be upregulated in transdifferentiated renal proximal tubular cells. This review summarizes emerging evidence implicating gremlin in the pathophysiology of glomerulosclerosis and tubulointerstitial fibrosis. Gremlin is a potential novel therapeutic target in progressive renal diseases.

Original languageEnglish
Pages (from-to)241-244
Number of pages4
JournalExperimental Nephrology
Volume10
Issue number4
DOIs
Publication statusPublished - 2002
Externally publishedYes

Keywords

  • Bone morphogenetic proteins
  • drm
  • Extracellular matrix
  • Fibrogenesis
  • Gremlin
  • Hypertrophy
  • Kidney development
  • Mesangial cells
  • Transdifferentiation
  • Transforming growth factor-β
  • Tubule epithelial cells

Fingerprint

Dive into the research topics of 'Gremlins: Is this what renal fibrogenesis has come to?'. Together they form a unique fingerprint.

Cite this